The Aerogen Ultra offers superior drug delivery and improved patient response in the Emergency Department.
New clinical outcome data demonstrates how Aerogen Ultra is transforming the treatment of patients in the Emergency Department
A retrospective chart review of 1,594 patients at St. John Hospital and Medical Center, Detroit compared clinical outcomes associated with the use of a hospital standard small volume nebuliser (SVN) versus the Aerogen Ultra.
Lung dose delivered: Aerogen Ultra 34.1%; Jet Nebuliser 5.2% (p < 0.001)
Residual dose volume: Aerogen Ultra 2.4%; Jet Nebuliser 62.8% (p = 0.008)
Nebulisers were filled with diethylenetriaminepentaacetic acid labelled with
technetium-99 m (99mTc-DTPA, 2 mCi/4 mL) Dugernier J. et al 20174
*Aerogen Ultra compared to a standard Jet Nebuliser.
Our unique palladium vibrating mesh technology, Aerogen Vibronic® is a breakthrough in aerosol drug delivery and is at the heart of all our products.
The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.
1. Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gidwani S. Poster at the College of Emergency Medicine Clinical Excellence Conference. 2014. 2.Cushen B, Alsaid A, Abdulkareem A and Costello RW. ITS poster presentation. 2016. 3. Dunne RB and Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. The American journal of emergency medicine. 2017